- Home
- MTN vs GH Comparison
MTN vs GH Comparison
Compare MTN & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTN
- GH
- Stock Information
- Founded
- MTN 1997
- GH 2011
- Country
- MTN United States
- GH United States
- Employees
- MTN N/A
- GH N/A
- Industry
- MTN Services-Misc. Amusement & Recreation
- GH Medical Specialities
- Sector
- MTN Consumer Discretionary
- GH Health Care
- Exchange
- MTN Nasdaq
- GH Nasdaq
- Market Cap
- MTN 5.2B
- GH 4.9B
- IPO Year
- MTN 1997
- GH 2018
- Fundamental
- Price
- MTN $156.68
- GH $49.14
- Analyst Decision
- MTN Hold
- GH Strong Buy
- Analyst Count
- MTN 10
- GH 20
- Target Price
- MTN $186.50
- GH $54.35
- AVG Volume (30 Days)
- MTN 1.0M
- GH 2.2M
- Earning Date
- MTN 06-05-2025
- GH 08-06-2025
- Dividend Yield
- MTN 5.68%
- GH N/A
- EPS Growth
- MTN 6.60
- GH N/A
- EPS
- MTN 7.74
- GH N/A
- Revenue
- MTN $2,958,444,000.00
- GH $773,996,000.00
- Revenue This Year
- MTN $3.77
- GH $23.14
- Revenue Next Year
- MTN $3.71
- GH $21.42
- P/E Ratio
- MTN $20.20
- GH N/A
- Revenue Growth
- MTN 2.38
- GH 28.20
- 52 Week Low
- MTN $129.85
- GH $20.14
- 52 Week High
- MTN $199.45
- GH $52.92
- Technical
- Relative Strength Index (RSI)
- MTN 55.93
- GH 62.17
- Support Level
- MTN $147.53
- GH $48.00
- Resistance Level
- MTN $160.70
- GH $51.71
- Average True Range (ATR)
- MTN 4.56
- GH 2.67
- MACD
- MTN -0.22
- GH 0.39
- Stochastic Oscillator
- MTN 69.48
- GH 78.60
About MTN Vail Resorts Inc.
Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.